非小细胞肺癌化疗

Chemotherapy for non-small cell lung cancer

以上为机器翻译结果，快速获取精准的人工翻译结果，建议选择有道人工翻译

1
特罗凯在美国和欧盟被批准用于非小细胞肺癌化疗后一线治疗。
Tarceva approved in US and EU for first-line treatment of non-small-cell lung cancer after chemotherapy.
2
抑制肿瘤新生血管的生成有望降低甚或遏制对非小细胞肺癌化疗的耐药性。
Inhibition of angiogenesis in tumor is expected to reduce or inhibit drug resistance to NSCLC.
3
目的明确肿瘤组织胰岛素样生长因子-1受体（IGF-1R）表达对晚期非小细胞肺癌化疗疗效及生存的影响。
ObjectiveTo explore the influence of the expression of insulin-like growth factor-1 receptor(IGF-1R)in end-stage non-small cell lung cancer.

点击反馈